Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation
Individual results vary based on starting weight, dose, adherence, and other factors
Typically, you may be a candidate for GLP-1 therapy if you meet one of the following criteria: A BMI of 30 or higher, which is classified as obesity
WeightWatchers Med+ is now offering Novo Nordisks brand new Wegovy pill, the first FDAapproved oral GLP1 for weight loss
Learn more about our Employee Benefits Consulting services: Why GLP-1 Coverage Has Become Such a Big Issue GLP-1 medications can cost hundreds of dollars per month after rebates and manufacturer discounts, with utilization continuing to increase across employer-sponsored health plans
Lyophilized or stable powder form for long shelf-life